Business development
As a leading biopharma company, partnering is a key priority for us. We are leading scientific innovation in our core therapeutic areas - oncology, hematology, immunology, cardiovascular and neuroscience - and collaborating at the center of the biotech ecosystem, complementing our internal scientific expertise with collaborations to drive innovation.
 |
19/22 |
 |
>60% |
 |
300+ |
Working together
We have a distinct and decisive approach to partnering that leverages the best of Bristol Myers Squibb and the best of our partners to speed transformational medicines to patients. We strive to be a partner of choice and establish a creative and customized approach for each agreement.
Learn more about our fully dedicated group of experienced leaders that serve as the primary point of contact to foster and strengthen the relationship between Bristol Myers Squibb and partners.
Every day, each of us works to improve outcomes for patients fighting serious diseases. Together, we're building a better future for each other and the patients who need us most.